Evidence map›Paper›PMID 41910192›Full record

ArticleGlycobiology2026

Exploratory analyses of cervicovaginal mucus O-glycan composition and microbiota profiles in unexplained infertility.

Schahzad Saqib, Dimitrios Latousakis, Seppo Virtanen, Ilkka Kalliala, Tiina Holster, Nathalie Juge, Anne Salonen

Abstract read
In one paragraph

Article in Glycobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Schahzad SaqibHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.ORCID 0000-0002-0844-2124
Dimitrios LatousakisThe Food, Microbiome and Health Institute Strategic Programme, Rosalind Franklin Road, Norwich Research Park, Quadram Institute Bioscience, NR4 7UQ, Norwich, United Kingdom.
Seppo VirtanenHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
Ilkka KallialaHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
Tiina HolsterDepartment of Obstetrics and Gynaecology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.ORCID 0000-0003-0257-1256
Nathalie JugeThe Food, Microbiome and Health Institute Strategic Programme, Rosalind Franklin Road, Norwich Research Park, Quadram Institute Bioscience, NR4 7UQ, Norwich, United Kingdom.ORCID 0000-0001-8515-1315
Anne SalonenHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.

Funding

Biotechnology and Biological Sciences Research CouncilEuropean Union's Horizon 2020 research and innovation programme 814102; to A.S. & N.J.Institute Strategic Programme Food Microbiome and Health BB/X011054/1
6 · The paper itself

Abstract

In addition to the specific causes of infertility, two components of the vaginal ecosystem, the vaginal microbiota and the cervicovaginal mucus (CVM), may be associated to reduced fecundity and the success of infertility treatments. The aim of this study was to explore the composition of the CVM O-glycans and vaginal microbiota in women with unexplained infertility. We collected CVM and vaginal swab samples during medically induced ovulation from 19 women with unexplained infertility. Mucin O-glycosylation profiles were generated through Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI-ToF) mass spectrometry and taxonomic profiles of the vaginal microbiota through 16S rRNA gene amplicon sequencing. Altogether 57 O-glycan structures were identified, dominated by core 1 and 2 structures. A significant proportion, nearly 85%, of the glycans were fucosylated and five structures dominated the profiles, accounting for >50% of the glycans observed in most samples. The vaginal microbiota of the patients was dominated by Lactobacillus crispatus (79%), followed by Lactobacillus jensenii (32%) and Lactobacillus iners (21%) and Gardnerella vaginalis (5%, single sample). PERMANOVA analysis indicated significant associations between the glycan structures and dominant taxa (q = 0.0011, R2 = 0.37). This exploratory study provides initial insights into the composition and variation of CVM O-glycans in unexplained fertility and in relation to the vaginal microbiota composition, laying a groundwork for future research.

Indexed as

Cervix MucusInfertility, FemaleMicrobiotaPolysaccharidesVaginaAdultFemaleGardnerella vaginalisHumansLactobacillusRNA, Ribosomal, 16SPolysaccharidesRNA, Ribosomal, 16Scervicovaginal mucusFucosylationO-glycans/unexplained infertilityvaginal microbiome

Identifiers

PMID41910192
PMCPMC13082223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.